Arecent large study from Denmark sought to determine if men who regularly took aspirin after being diagnosed with prostate cancer had a lower risk of dying from the disease. While the study did not find an overall link between aspirin use and prostate cancer mortality rates, the research suggested a possible benefit for men five years after a diagnosis.
Earlier research on this topic has been inconclusive. QUEST previously reported on a study in 2017 that found a beneficial relationship between regular aspirin use and prostate cancer. Further research is needed to assess the impact of aspirin on prostate cancer.
Ann Intern Med. 2019 Mar 5. doi: 10.7326/M17-3085.